IngentaConnect A single measurement of CD38CD8 cells in HIV, long-term surviving...

Authors: Froebel, K. S.¹; Raab, G. M.²; D'alessandro, C.¹; Armitage, M. P.¹; Mackenzie, K. M.²; Struthers, M.²; Whitelaw, J. M.³; Yang, S.²

Source: Clinical & Experimental Immunology, Volume 122, Number 1, October 2000 , pp. 72-78(7)

Publisher: Blackwell Publishing

Abstract:

This study compares the predictive power of a single measurement of CD8⁺CD38⁺, CD8+CD45RO⁺ or CD8⁺CD38⁺CD45RO⁺ subpopulations in predicting progression to AIDS in a cohort of HIV⁺ long-term surviving injecting drug users. The results showed that both the total CD8⁺ percentage, and the CD8⁺CD38⁺ and CD8⁺CD38⁺CD45RO⁺ subpopulations of cells all individually predicted progression to AIDS. In combination with CD4, only the CD8⁺CD38⁺ subpopulation enhanced the predictive power of the CD4 percentage alone. The CD8⁺ percentage correlated negatively with the CD4 percentage and the CD8⁺CD45RO⁺ subpopulation did not predict disease progression. The proportion of CD8⁺CD38⁺ cells identified which patients with a moderate CD4 level were more likely to progress to AIDS, and conversely, which patients with a low CD4 count were likely to remain clinically stable. The results were consistent irrespective of whether time was measured from the date of seroconversion, or from the date of the test. This study is the first to measure these markers in HIV-infected injecting drug users, and in long-term survivors. The results demonstrate the considerable added value of the CD8⁺CD38⁺ cell percentage over the CD4 count alone, in predicting HIV clinical progression.

Keywords: HIV; clinical progression; flow cytometry; CD38; CD8 subpopulations

Document Type: Research article

DOI: 10.1046/j.1365-2249.2000.01348.x

Affiliations: 1: Centre for HIV Research, ICAPB, University of Edinburgh, 2: Applied Statistics Group, Department of Mathematics, Napier University, and 3: HIV Immunology Unit, Royal Infirmary, Edinburgh, UK

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable

A single measurement of CD38CD8 cells in HIV⁺, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable